Reutens AT, Jandeleit-Dahm K, Thomas M et al (2020) A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations
I wanted to see my grandkids graduate from high school, so I was really going to follow the rules." Pat is no longer on Zepbound but says it has been worth it
Sept 2012
A 2023 review found that astaxanthin may reduce inflammation and bone pain
At Second Nature, weve been used by the NHS since 2017 to support people with type 2 diabetes and obesity to lose weight, manage their blood sugar levels, and lead healthier lifestyles for the long term